赫西丁和亚历克西丁抑制NMDA受体的机制
Arseniy S Zhigulin1, Oleg I Barygin1
1I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry RAS, Saint-Petersburg, Russia.
Biochemical and biophysical research communications
|December 19, 2025
概括
两个bisbiguanide化合物,赫西丁和亚历克西丁,强烈抑制NMDA受体. 这一发现为开发针对这些关键大脑受体的药物提供了新的途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
- 分子生物学分子生物学
背景情况:
- NMDA受体是中枢神经系统中关键的离子通道.
- 包括瓜尼丁在内的基化合物是已知的NMDA受体抑制剂.
- 在NMDA受体上,bisbiguanide化合物的抑制机制在很大程度上仍未被探索.
研究的目的:
- 为了研究赫西丁和亚历克西丁对本源NMDA受体的抑制活性.
- 描述这些bisbiguanide化合物对NMDA受体的作用机制.
主要方法:
- 全细胞补丁记录在孤立的老鼠CA1海马体金字塔神经元上进行.
- 原生NMDA受体在受控电压条件下进行了研究 (-80mV持有潜力).
- 分析了剂量反应关系,以确定抑制的IC50值.
主要成果:
- 赫西丁和亚历克西丁证明了NMDA受体的强烈抑制,其IC50值分别为81 ± 5nM和144 ± 13nM.
- 这些双双化物化合物比以前研究的单双化物更为有效的抑制剂.
- 抑制是可逆的,非竞争性的,并且在很大程度上独立于电压,这表明一种全osteric 机制.
结论:
- 赫西丁和亚历克西丁是天然NMDA受体的强有力的全抑制剂.
- 这项研究扩大了对与NMDA受体的比古安化物化合物相互作用的理解.
- 这些发现为开发针对NMDA受体的新疗法提供了基础.
相关概念视频
Hand hygiene
5.4K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
5.4K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
884
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
884
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
512
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
512


